In 2024, Medicaid payments in Dyersburg totaled no less than $349,195 for services identified under COVID-19–specific HCPCS codes, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows. This marked an 18.1% growth over the prior year, when claims for the same codes totaled $295,814.
Medicaid, a public insurance program, is managed by states with funding from both federal and state sources. It primarily serves low-income groups, seniors, children and individuals with disabilities, making it a cornerstone of the health system in the U.S.
Because it is funded by taxpayers, shifts in Medicaid billing in a community reflect public health funding allocation at the local level.
This report used HCPCS codes classified or described as “COVID-19” or “coronavirus” in billing data to identify virus-related services. The figures here only count payments directly labeled as COVID-related, which may exclude pandemic-related services included under more general or alternate codes.
By comparison, Spring Hill led Tennessee in 2024 for COVID-19 Medicaid claims, with $4,274,403 in payments linked to virus-specific services.
Six providers in Dyersburg filed Medicaid claims tied to COVID-19 services in 2024. The Immunoassay code led with $210,962 in claims.
Dyersburg’s average Medicaid payment per provider for COVID-19–related services reached $58,199, which exceeded the statewide average of $43,799.
Services designated as COVID-19–specific contributed only marginally to Medicaid spending growth during the pandemic years in Dyersburg.
For all other categories, Medicaid payments increased by $741,027 from 2020 to 2024—an 8% rise in this period.
In the two years before the pandemic, annual average Medicaid payments in Dyersburg were $10,116,697.
Between 2020 and 2024, payments for Medicaid services using COVID-19–related HCPCS codes increased by $340,194, or 3,779.5%, signaling continued service volume into the post-emergency period.
The Centers for Medicare & Medicaid Services reports that total Medicaid spending from federal and state sources rose to about $871.7 billion in fiscal year 2023, representing around 18% of total national health care spending—up from roughly $613.5 billion in 2019 before the pandemic.
This represents nearly 40% growth in just a few years, driven mainly by enrollment expansions and increased service use during and following the pandemic.
Recent federal budget actions during the Trump administration included sizable proposed Medicaid funding reductions and restructuring of the program. The “One Big Beautiful Bill Act,” enacted in 2025, is projected to cut federal Medicaid funding by over $1 trillion over 10 years and imposes new measures such as work requirements and greater cost-sharing for some users, which may narrow coverage and funding. These changes are set to shift additional costs to states and may restrain federal Medicaid funding growth while the program continues to support tens of millions of Americans.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $349,195 | 18% | $10,396,391 |
| 2023 | $295,814 | 200.3% | $13,524,494 |
| 2022 | $98,492 | 207.3% | $13,951,538 |
| 2021 | $32,049 | 256.1% | $13,129,768 |
| 2020 | $9,001 | N/A | $9,315,170 |
| 2019 | $0 | N/A | $10,022,385 |
| 2018 | $0 | N/A | $10,211,009 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $210,962 | 6,766 |
| 87635 | COVID Specific | $138,233 | 3,087 |
Note: Totals include HCPCS codes explicitly assigned for COVID-19 services; numbers do not fully reflect all health spending tied to the pandemic.
This article’s information sources include the U.S. Department of Health and Human Services Medicaid Provider Spending database. The full dataset is available here.


